
Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men’s treatment decisions after seeing a rise in their PSA levels. <

Your AI-Trained Oncology Knowledge Connection!


Published: July 24th 2014 | Updated: